Guideline summary : appropriate use of tigecycline

Brink, Adrian J.; Bizos, D.; Boffard, Kenneth D.; Feldman, Charles; Grolman, D.C.; Pretorius, J.; Richards, Guy A.; Steyn, E.

dc.contributor.author	Brink, Adrian J.
dc.contributor.author	Bizos, D.
dc.contributor.author	Boffard, Kenneth D.
dc.contributor.author	Feldman, Charles
dc.contributor.author	Grolman, D.C.
dc.contributor.author	Pretorius, J.
dc.contributor.author	Richards, Guy A.
dc.contributor.author	Steyn, E.
dc.date.accessioned	2012-03-30T06:25:04Z
dc.date.available	2012-03-30T06:25:04Z
dc.date.issued	2012-02
dc.description.abstract	Tigecycline, the first of a new class of broad-spectrum antibiotics (the glycylcyclines), has been licensed in South Africa for the parenteral treatment of adult patients with complicated intra-abdominal infections (cIAIs) and complicated skin and soft-tissue infections (cSSTIs).	en_US
dc.description.uri	http://www.hmpg.co.za/journaldetail.php?journalno=8	en_US
dc.identifier.citation	Brink, AJ, Bizos, D, Boffard, KD, Feldman, C, Grolman, DC, Pretorius, J, Richards, GA & Steyn, E 2012, 'Guideline summary : appropriate use of tigecycline', South African Journal of Surgery, vol. 50, no. 1, pp. 20-21.	en_US
dc.identifier.issn	0038-2361 (print)
dc.identifier.issn	2078-5151 (online)
dc.identifier.uri	http://hdl.handle.net/2263/18524
dc.language.iso	en	en_US
dc.publisher	Health and Medical Publishing Group	en_US
dc.rights	Health and Medical Publishing Group	en_US
dc.subject	Tigecycline	en_US
dc.subject	Directed combination therapy	en_US
dc.subject	Directed monotherapy	en_US
dc.subject	Empiric monotherapy	en_US
dc.title	Guideline summary : appropriate use of tigecycline	en_US
dc.type	Article	en_US